Parabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss
Molecular Metabolism · 2026-12 · 114 · 102453
DOI: 10.1016/j.molmet.2026.102453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Metabolism, 2026-12. Verfasst von Haley S Province und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL 60611, USA; Northwestern I…. Hauptthemen laut MEDLINE: Calcitonin Gene-Related Peptide, Neurons, Incretins, Parabrachial Nucleus. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, McKnight Endowment Fund for Neuroscience, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Incretin mimetics such as the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide cause decreased food intake, weight loss, and aversion. Here, we examined the extent to which parabrachial calcitonin gene-related peptide (CGRP) neurons contribute to these effects. Further, we assessed whether glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism alters liraglutide-induced behavior and CGRP neuron activity. We found that liraglutide activates parabrachial CGRP neurons and that this is required for liraglutide-induced aversion, but not anorexia or weight loss. Additionally, treatment with a GIPR agonist (GIPRA) or the well-established anti-emetic drug ondansetron ameliorated liraglutide-induced conditioned taste avoidance (CTA) and CGRP neuron activation without affecting acute liraglutide-induced feeding suppression. Taken together, our findings demonstrate that the aversive and anorexigenic effects of liraglutide are mediated by distinct neural mechanisms that can be separably manipulated. Our findings also highlight GIPR agonism as an emerging anti-aversive approach to GLP-1RA-induced malaise while maintaining the beneficial metabolic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL 60611, USA; Northwestern Interdepartmental Neuroscience Graduate Program, Northwestern Universit…
- Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA.
- Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL 60611, USA.
- Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: lisa.beutler@northwestern.edu.
Förderung
- NIDDK NIH HHS
- McKnight Endowment Fund for Neuroscience
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Province, H. S., Leong, N. A., Conley, N. J., Hayes, N. W., Tang, E., & Beutler, L. R. (2026). Parabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss. Molecular Metabolism, 114, 102453. https://doi.org/10.1016/j.molmet.2026.102453
Vancouver
Province HS, Leong NA, Conley NJ, Hayes NW, Tang E, Beutler LR. Parabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss. Molecular Metabolism. 2026;114:102453. doi:10.1016/j.molmet.2026.102453
BibTeX
@article{Province2026,
author = {Province, Haley S and Leong, Nathan A and Conley, Nicholas J and Hayes, Nikolas W and Tang, Esther and Beutler, Lisa R},
title = {Parabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss},
journal = {Molecular Metabolism},
year = {2026},
volume = {114},
pages = {102453},
doi = {10.1016/j.molmet.2026.102453}
}
EUVIMED